Patient-Reported Shoulder Morbidity and Fatigue among Breast Cancer Survivors: An Insight from a Tertiary Care Cancer Hospital

Abstract

Context: Breast cancer is the most common cancer in Indian women with an annual mortality of around 87,000. Treatment for breast carcinoma may lead to swelling of the ipsilateral arm, shoulder stiffness, arm pain, and cancer-related fatigue. Very few centers in India have reported the arm and shoulder morbidity treated in their hospitals. Aims: The aim was to evaluate the predictive factors of arm and shoulder morbidity and fatigue among breast cancer survivors. Settings and Design: This was a retrospective analysis based on a prospectively maintained database. Materials and Methods: Early and locally advanced cases of breast cancer patients were screened for the study during 2015–2018. Eligible participants were invited to fill up the predetermined questionnaire, and their demographic and treatment-related information was accrued from a file archive. Follow-up period was estimated from the date of tissue diagnosis to last contact/time of interview. Results: Shoulder stiffness was the most common complaint followed by arm numbness. Obesity and diabetes played a crucial role in most of the morbidities and fatigue. The median fatigue score was 34, and the median time of appearance of lymphedema was 13 months. Modified radical mastectomy and radiotherapy to axilla were statistically significantly (P = 0.04 and 0.01, respectively) associated with greater shoulder stiffness and arm swelling. Conclusions: Obesity, diabetes, type of surgery, the extent of axillary dissection, and radiation plan are the major predictive factors of arm and shoulder morbidity. Further prospective validation is necessary for future breast cancer survivorship programs.

Keywords

Breast cancer - patient-reported outcome - shoulder morbidity - survivorship

Publication History

Received: 24 May 2020

Accepted: 11 September 2020

Article published online:
14 May 2021

• References

• 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
• 2 Freitas-Silva R, Conde DM, de Freitas-Júnior R, Martinez EZ. Comparison of quality of life, satisfaction with surgery and shoulder-arm morbidity in breast cancer survivors submitted to breast-conserving therapy or mastectomy followed by immediate breast reconstruction. Clinics (Sao Paulo) 2010; 65: 781-7
• 3 de Groef A, van KampenM, Tieto E, Schönweger P, Christiaens MR, Neven P. et al. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study. Breast 2016; 29: 102-8
• 4 Koehler LA, Blaes AH, Haddad TC, Hunter DW, Hirsch AT, Ludewig PM. Movement, function, pain, and postoperative edema in axillary web syndrome. Phys Ther 2015; 95: 1345-53
• 5 Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM. et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006; 95: 279-93
• 6 Shamley D, Srinaganathan R, Oskrochi R, Lascurain-Aguirrebeña I, Sugden E. Three-dimensional scapulothoracic motion following treatment for breast cancer. Breast Cancer Res Treat 2009; 118: 315-22
• 7 Harris SR, Hugi MR, Olivotto IA, Levine M. Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer Clinical practice guidelines for the care and treatment of breast cancer: 11.Lymphedema. CMAJ 2001; 164: 191-9
• 8 Ferrandez JC, Serin D, Bouges S. Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases. Bull Cancer 1996; 83: 989-95
• 9 Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR. et al. Arm edema in conservatively managed breast cancer: Obesity is a major predictive factor. Radiology 1991; 180: 177-84
• 10 Suneson BL, Lindholm C, Hamrin E. Clinical incidence of lymphoedema in breast cancer patients in JoÈ nkoÈ ping County, Sweden. Eur J Cancer are (Engl Lang Ed) 1996; 5: 7-2
• 11 McCredie MR, Dite GS, Porter L, Maskiell J, Giles GG, Phillips KA. et al. Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast 2001; 10: 515-22
• 12 Acaster S, Dickerhoof R, DeBusk K, Bernard K, Strauss W, Allen LF. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes 2015; 13: 60
• 13 Sinha S, Edwards TL. Prevalence and aetiology of lymphoedema after breast cancer treatment in Southern Tasmania. Aust N Z J Surg 2000; 70: 412-8
• 14 Mortimer PS, Bates DP, Brassington HD, Stanton AW, Strachan DP, Levick JR. The prevalence of arm oedema following treatment for breast cancer. Q J M 1996; 89: 377-80
• 15 Paci E, Cariddi A, Barchielli A, Bianchi S, Cardona G, Distante V. et al. Long-term sequelae of breast cancer surgery. Tumori 1996; 82: 321-4
• 16 Kissin MW, Querci della RovereG, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-4
• 17 Kootstra JJ, Dijkstra PU, Rietman H, de Vries J, Baas P, Geertzen JH. et al.2013 A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat 2013; 139: 125-4
• 18 Kramer N, Ramjith J, Shamley D. Prevalence of shoulder morbidity after treatment for breast Cancer in South Africa. Support Care Cancer 2019; 27: 2591-8
• 19 Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66: 136-8
• 20 Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: A critical review of risk factors and strategies for prevention. J Pain 2011; 12: 725-46
• 21 Alves Nogueira FabroE, Bergmann A, do Amaral E SilvaB, Padula RibeiroAC, de Souza AbrahãoK, da Costa Leite FerreiraMG. et al. ost-mastectomy pain syndrome: Incidence and risks. Breast 2012; 21: 321-5
• 22 Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 2003; 80: 39-48
• 23 Kudel I, Edwards RR, Kozachik S, Block BM, Agarwal S, Heinberg LJ. et al. Predictors and consequences of multiple persistent postmastectomy pains. J Pain Symptom Manage 2007; 34: 619-27
• 24 Miaskowski C, Cooper B, Paul SM, West C, Langford D, Levine JD. et al. Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain 2012; 13: 1172-87
• 25 Krueger AB, Stone AA. Assessment of pain: A community-based diary survey in the USA. Lancet 2008; 371: 1519-25
• 26 Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2011; 25: 173-83
• 27 Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI. et al. Risk factors for chronic pain following breast cancer surgery: A prospective study. J Pain 2006; 7: 626-34
• 28 Shamley D, Lascurain-aguirrebeña I, Oskrochi R. Shoulder morbidity after treatment for breast cancer is bilateral and greater after mastectomy. Acta Oncol (Madr) 2012; 51: 1045-3